NLS Pharmaceutics (NLSP) has released an update.
NLS Pharmaceutics Ltd. has successfully regained compliance with Nasdaq’s minimum stockholders’ equity requirement. The company achieved this by raising $3.2 million through security sales and converting certain debts into preferred stock, ensuring their continued listing on the Nasdaq Capital Market.
For further insights into NLSP stock, check out TipRanks’ Stock Analysis page.
